# Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-temsirolimus-in-women-with-recurrent-or-metastatic-endometrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amit M. Oza,Laurie Elit,Ming‐Sound Tsao,Suzanne Kamel‐Reid,Jim Biagi,Diane Provencher,Walter H. Gotlieb,Paul Hoskins,Prafull Ghatage,Katia Tonkin,Helen Mackay,J. Mazurka,Joana Sederias,Percy Ivy,Janet Dancey,Elizabeth A. Eisenhauer |
| Citations | 341 |
| DOI | 10.1200/jco.2010.34.1578 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.34.1578?role=tab |
| OpenAlex ID | https://openalex.org/W2119607431 |
| PMID | 21788564 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [Laurie Elit](https://scholariq.org/researchers/laurie-elit/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Protein Tyrosine Phosphatases](https://scholariq.org/topics/protein-tyrosine-phosphatases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.